Named as a key player in 231 of our reports, across 33 regions and countries.
Our reports that name Karl Storz SE & Co. KG as a key player, by category and place.
Markets where they are a key player. Each opens the market's statistics for every place we cover.
None of their markets match.
Our newest markets with them as a key player. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Named as key players in the same markets as Karl Storz SE & Co. KG (number of shared markets).
Medtronic4 shared markets
Boston Scientific Corporation3 shared markets
Stryker3 shared markets
Ambu A/S2 shared markets
B. Braun Melsungen AG2 shared markets
Bovie Medical Corporation1 shared market
Caresyntax1 shared market
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
89 510(k) clearances and PMA approvals since 2015
Source: FDA 510(k) and PMA databases, 510(k) clearances, and PMA approvals or changes, since 2015; newest shown. Includes Karl Storz Endoscopy America, Inc.. Retrieved 13 Nov 2026.
71 recalls since 2015 (71 for devices)
Source: openFDA, FDA enforcement reports (recalls) naming the firm, since 2015. Includes Karl Storz Endoscopy America, Inc.. Retrieved 13 Nov 2026.
Markets we cover where free public records show Karl Storz SE & Co. KG: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Karl Storz SE & Co. KG is in.
Stories on the topics Karl Storz SE & Co. KG works in.
About 321,000 people were diagnosed with brain and nervous system tumours in 2022, and about 248,000 died…
Read
Behind every insurance claim is a standard electronic message. The CAQH Index says $20 billion a year could…
Read
Nearly 15% of US Medicare beneficiaries, 8.2 million people, had a wound or wound infection in one year…
Read